Prostate Cancer Plasma
About: Prostate Cancer Plasma samples are collected from donors diagnosed with Prostate Cancer (PCa). Suitable for analyzing circulating tumor DNA (ctDNA), PSA levels, cytokines, and other biomarkers linked to disease progression and therapeutic response in PCa.
| Lot # | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 76763 | Prostate Cancer | 2.0 ML | 64 | Male | Ukraine |
No medications
|
1 | $667.00 | ||
| 76762 | Prostate Cancer | 2.0 ML | 64 | Male | Ukraine |
No medications
|
1 | $667.00 | ||
| 76752 | Prostate Cancer | 3.0 ML | 68 | Male | Ukraine |
No medications
|
1 | $667.00 | ||
| 79110 | Prostate Cancer | 1.0 ML | 52 | Male |
No medications
|
1 | $667.00 | |||
| 79111 | Prostate Cancer | 1.0 ML | 52 | Male |
No medications
|
1 | $667.00 | |||
| 79112 | Prostate Cancer | 1.0 ML | 52 | Male |
No medications
|
1 | $667.00 | |||
| 79134 | Prostate Cancer | 1.0 ML | 72 | Male |
No medications
|
1 | $667.00 | |||
| 79113 | Prostate Cancer | 1.0 ML | 52 | Male |
No medications
|
1 | $667.00 | |||
| 79272 | Prostate Cancer | 1.0 ML | 72 | Male |
No medications
|
1 | $667.00 | |||
| 79135 | Prostate Cancer | 1.0 ML | 72 | Male |
No medications
|
1 | $667.00 |
Prostate Cancer Plasma | High-Quality Human Plasma from Prostate Cancer Donors
Prostate Cancer Plasma is collected from donors clinically diagnosed with Prostate Cancer and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in prostate cancer pathophysiology.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed Prostate Cancer donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified Prostate Cancer diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional prostate cancer-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Prostate Cancer plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – Comprehensive medical records are available and may contain information regarding autoantibody status.
1 Answer
YES – Sanguine offers both inventory for select conditions, as well as, prospective collection. For inventory visit https://sanguinebio.com/products/plasma/?pro_inventory=inventory.
1 Answer
We never thaw our plasma samples before shipping.
1 Answer
Our standard aliquot size for plasma is 1 mL but we have bulk plasma (50 to 150 mL) available for select conditions. https://sanguinebio.com/product/human-bulk-plasma/
1 Answer
YES – Sanguine bio provides “age-matched healthy controls” and longitudinal studies capabilities.
1 Answer
YES – custom age specifications available – The “Specify I/E Criteria” service allows you to define specific age ranges for donor selection.
1 Answer
Age ranges available – Donor metadata includes age specifications, and you can specify inclusion/exclusion criteria. For pediatric samples specifically, contact learnmore@sanguinebio.com.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.